Texas
LATEST FROM BIOSPACE
Here are some thoughts on breaking into the biomechanical engineering market.
A look at some of the superstitions and rituals that scientists apply to their work.
The deal is expected to close in the first quarter of 2018.
It’s no secret that the life sciences are increasingly international.
Here are five trends job hunters may see in the life sciences next year.
A look at the 19 spine-related medical devices the FDA cleared in October.
Mr. Hartman overviewed the Company’s Anti-Cancer R&D program and discussed his intent to find a licensee for the technology or investment partner to complete the development of this very promising anti-cancer antibody drug.
Baker and ex-ArthroCare CFO Michael Gluk were convicted in June 2014 on charges that they ran a scheme to generate false revenue numbers
For most biopharma sponsors, the crux of their challenge is how to identify an adequate number of evaluable patients to sufficiently power their late phase clinical research.
Corinnova’s CEO says the company has developed a device called EpicHeart to tackle heart failure.
PRESS RELEASES